| Bioactivity | Glymidine sodium is an oral active antidiabetic. Glymidine sodium is the inhibitor of hepatic lipolysis. Glymidine sodium inhibits the glucose formation and supresses the elevated pyruvate oxidation which results from the inhibition of endogenous lipid mobilization[1]. |
| Name | Glymidine sodium |
| CAS | 3459-20-9 |
| Formula | C13H14N3NaO4S |
| Molar Mass | 331.32 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Menahan LA, et al. The role of endogenous lipid in gluconeogenesis and ketogenesis of perfused rat liver. Eur J Biochem. 1969;9(2):182-188. |
Glymidine sodium
CAS: 3459-20-9 F: C13H14N3NaO4S W: 331.32
Glymidine sodium is an oral active antidiabetic. Glymidine sodium is the inhibitor of hepatic lipolysis. Glymidine sodiu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.